The Application of Embelin for Cancer Prevention and Therapy†
AbstractEmbelin is a naturally-occurring benzoquinone compound that has been shown to possess many biological properties relevant to human cancer prevention and treatment, and increasing evidence indicates that embelin may modulate various characteristic hallmarks of tumor cells. This review summarizes the information related to the various oncogenic pathways that mediate embelin-induced cell death in multiple cancer cells. The mechanisms of the action of embelin are numerous, and most of them induce apoptotic cell death that may be intrinsic or extrinsic, and modulate the NF-κB, p53, PI3K/AKT, and STAT3 signaling pathways. Embelin also induces autophagy in cancer cells; however, these autophagic cell-death mechanisms of embelin have been less reported than the apoptotic ones. Recently, several autophagy-inducing agents have been used in the treatment of different human cancers, although they require further exploration before being transferred from the bench to the clinic. Therefore, embelin could be used as a potential agent for cancer therapy. View Full-Text
Share & Cite This Article
Ko, J.-H.; Lee, S.-G.; Yang, W.M.; Um, J.-Y.; Sethi, G.; Mishra, S.; Shanmugam, M.K.; Ahn, K.S. The Application of Embelin for Cancer Prevention and Therapy. Molecules 2018, 23, 621.
Ko J-H, Lee S-G, Yang WM, Um J-Y, Sethi G, Mishra S, Shanmugam MK, Ahn KS. The Application of Embelin for Cancer Prevention and Therapy. Molecules. 2018; 23(3):621.Chicago/Turabian Style
Ko, Jeong-Hyeon; Lee, Seok-Geun; Yang, Woong M.; Um, Jae-Young; Sethi, Gautam; Mishra, Srishti; Shanmugam, Muthu K.; Ahn, Kwang S. 2018. "The Application of Embelin for Cancer Prevention and Therapy." Molecules 23, no. 3: 621.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.